• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[61铜]ATSM作为用于纤维肉瘤成像的正电子发射断层显像(PET)放射性药物的临床前研究。

Preclinical studies of [61Cu]ATSM as a PET radiopharmaceutical for fibrosarcoma imaging.

作者信息

Jalilian Amir R, Rostampour Nima, Rowshanfarzad Pejman, Shafaii Kamaleddin, Kamali-Dehghan Mohsen, Akhlaghi Mehdi

机构信息

Nuclear Medicine Research Group Agricultural, Medical and Industrial Research School (AMIRS), Karaj, Iran.

出版信息

Acta Pharm. 2009 Mar;59(1):45-55. doi: 10.2478/v10007-009-0008-9.

DOI:10.2478/v10007-009-0008-9
PMID:19304557
Abstract

[61Cu]diacetyl-bis(N4-methylthiosemicarbazone) ([61Cu] ATSM) was prepared using in house-made diacetyl-bis(N4-methylthiosemicarbazone) (ATSM) ligand and [61Cu]CuCl2 produced via the natZn(p, x)61Cu (180 muA proton irradiation, 22 MeV, 3.2 h) and purified by a ion chromatography method. [61Cu]ATSM radiochemical purity was >98 %, as shown by HPLC and RTLC methods. [61Cu]ATSM was administered into normal and tumor bearing rodents for up to 210 minutes, followed by biodistribution and co-incidence imaging studies. Significant tumor/non-tumor accumulation was observed either by animal sacrification or imaging. [61Cu]ATSM is a positron emission tomography (PET) radiotracer for tumor hypoxia imaging.

摘要

利用自制的双乙酰双(N4-甲基硫代半卡巴腙)(ATSM)配体和通过天然锌(p,x)61铜(180微安质子辐照,22兆电子伏特,3.2小时)产生的[61铜]氯化铜制备了[61铜]双乙酰双(N4-甲基硫代半卡巴腙)([61铜]ATSM),并通过离子色谱法进行纯化。如高效液相色谱法和放射薄层色谱法所示,[61铜]ATSM的放射化学纯度>98%。将[61铜]ATSM注射到正常和荷瘤啮齿动物体内长达210分钟,随后进行生物分布和符合成像研究。通过动物处死或成像观察到明显的肿瘤/非肿瘤蓄积。[61铜]ATSM是一种用于肿瘤缺氧成像的正电子发射断层扫描(PET)放射性示踪剂。

相似文献

1
Preclinical studies of [61Cu]ATSM as a PET radiopharmaceutical for fibrosarcoma imaging.[61铜]ATSM作为用于纤维肉瘤成像的正电子发射断层显像(PET)放射性药物的临床前研究。
Acta Pharm. 2009 Mar;59(1):45-55. doi: 10.2478/v10007-009-0008-9.
2
Noninvasive 64Cu-ATSM and PET/CT assessment of hypoxia in rat skeletal muscles and tendons during muscle contractions.无创64Cu-ATSM与PET/CT对大鼠肌肉收缩过程中骨骼肌和肌腱缺氧情况的评估
J Nucl Med. 2009 Jun;50(6):950-8. doi: 10.2967/jnumed.109.062216. Epub 2009 May 14.
3
Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).PET显像剂64Cu(II)-双乙酰双(N4-甲基硫代半卡巴腙)缺氧选择性的瘤间差异
J Nucl Med. 2006 Jun;47(6):989-98.
4
Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.18F-氟阿霉素阿拉伯呋喃糖苷与 64Cu-二乙酰基双(N4-甲基硫代半卡巴腙)在癌症临床前模型中的比较。
J Nucl Med. 2013 Jul;54(7):1106-12. doi: 10.2967/jnumed.112.111120. Epub 2013 May 22.
5
Basic characterization of 64Cu-ATSM as a radiotherapy agent.64Cu-ATSM作为一种放射治疗剂的基本特性
Nucl Med Biol. 2005 Jan;32(1):21-8. doi: 10.1016/j.nucmedbio.2004.08.012.
6
Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.正电子发射断层扫描灌注剂铜-62-双硫辛酸甲酯的人体生物分布与剂量测定
J Nucl Med. 1998 Nov;39(11):1958-64.
7
Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone).用60Cu标记的双乙酰双(N4-甲基硫代半卡巴腙)通过正电子发射断层显像(PET)评估宫颈癌中的肿瘤缺氧情况。
J Nucl Med. 2008 Feb;49(2):201-5. doi: 10.2967/jnumed.107.048520. Epub 2008 Jan 16.
8
Assessment of tumor hypoxia by 62Cu-ATSM PET/CT as a predictor of response in head and neck cancer: a pilot study.62Cu-ATSM PET/CT 评估肿瘤乏氧作为头颈部肿瘤反应预测因子的初步研究。
Ann Nucl Med. 2011 Jun;25(5):339-45. doi: 10.1007/s12149-011-0471-5. Epub 2011 Feb 16.
9
Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.使用18F-氟米索硝唑和64Cu(II)-二乙酰基双(N4-甲基硫代半卡巴腙)正电子发射断层扫描评估局部肿瘤缺氧:在R3327-AT和FaDu大鼠肿瘤模型中进行的包括微型PET成像、氧分压探针测量、放射自显影和荧光显微镜检查的比较研究。
Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1493-502. doi: 10.1016/j.ijrobp.2004.12.057.
10
Production and tumour uptake of [64Cu]Pyruvaldehyde-bis (N4-methylthiosemicarbazone) for PET and/or therapeutic purposes.用于正电子发射断层扫描(PET)和/或治疗目的的[64Cu]丙酮醛双(N4-甲基硫代半卡巴腙)的制备及其在肿瘤中的摄取
Nucl Med Rev Cent East Eur. 2007;10(1):6-11.

引用本文的文献

1
Copper-61 is an advantageous alternative to gallium-68 for PET imaging of somatostatin receptor-expressing tumors: a head-to-head comparative preclinical study.对于表达生长抑素受体的肿瘤进行正电子发射断层显像(PET)时,铜-61是镓-68的一种有利替代物:一项直接比较的临床前研究。
Front Nucl Med. 2024 Oct 11;4:1481343. doi: 10.3389/fnume.2024.1481343. eCollection 2024.
2
Recent Advances in Cu/Cu-Based Radiopharmaceuticals.最新的铜/铜基放射性药物进展。
Int J Mol Sci. 2023 May 23;24(11):9154. doi: 10.3390/ijms24119154.
3
Production of GMP-Compliant Clinical Amounts of Copper-61 Radiopharmaceuticals from Liquid Targets.
从液体靶标生产符合药品生产质量管理规范(GMP)的临床用量的铜-61放射性药物。
Pharmaceuticals (Basel). 2022 Jun 7;15(6):723. doi: 10.3390/ph15060723.
4
Cu-ATSM internal radiotherapy to treat tumors with bevacizumab-induced vascular decrease and hypoxia in human colon carcinoma xenografts.铜-ATSM内照射放疗治疗贝伐单抗诱导的人结肠癌异种移植瘤血管减少和缺氧肿瘤。
Oncotarget. 2017 Sep 28;8(51):88815-88826. doi: 10.18632/oncotarget.21323. eCollection 2017 Oct 24.
5
Validation of 64Cu-ATSM damaging DNA via high-LET Auger electron emission.通过高传能线密度俄歇电子发射对64Cu-ATSM损伤DNA的验证。
J Radiat Res. 2015 Sep;56(5):784-91. doi: 10.1093/jrr/rrv042. Epub 2015 Aug 6.
6
PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.用于肿瘤缺氧成像的正电子发射断层显像(PET)放射性药物:证据综述
Am J Nucl Med Mol Imaging. 2014 Jun 7;4(4):365-84. eCollection 2014.
7
Controlled administration of penicillamine reduces radiation exposure in critical organs during 64Cu-ATSM internal radiotherapy: a novel strategy for liver protection.青霉胺的控制性给药可减少64Cu-ATSM内放疗期间关键器官的辐射暴露:一种肝脏保护的新策略。
PLoS One. 2014 Jan 22;9(1):e86996. doi: 10.1371/journal.pone.0086996. eCollection 2014.